Concepedia

Lorenza Wyder

LW

13

Publications

1.7K

Citations

13

H-Index

2000

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Actelion (Switzerland)

University Hospital of Zurich

Lorenza Wyder is an author at Novartis (Switzerland) specializing in medicine, cell biology, and vascular biology.

Top concepts

Publications per year

2000–2014

13

Publications

13

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

Louise E. Reynolds, Lorenza Wyder, Julie C. Lively et al. · Nature Medicine · 2002 · 608 citations

, , +10

Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization

Kenneth R. LaMontagne, Amanda Littlewood‐Evans, Christian Schnell et al. · Cancer Research · 2006 · 297 citations

Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent

Rita Andraos, Zhiyan Qian, Débora Bonenfant et al. · Cancer Discovery · 2012 · 126 citations · Full text

, , +21

Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805

Fabienne Baffert, Catherine H. Régnier, Alain De Pover et al. · Molecular Cancer Therapeutics · 2010 · 119 citations

, , +20

Reduced pathological angiogenesis and tumor growth in mice lacking GPR4, a proton sensing receptor

Lorenza Wyder, Thomas Suply, Bérangère Ricoux et al. · Angiogenesis · 2011 · 93 citations

, , +8

Rows per page

1–5 of 13